We are delighted to welcome you to the 12th World Congress on Controversies in Multiple Myeloma (COMy), taking place May 14–17, 2026, in Paris, France, with attendance both in-person and online.

COMy is a globally recognized conference dedicated to debating controversial topics in multiple myeloma medicine. With a strong commitment to evidence-based discussion, COMy brings together leading experts – clinicians, researchers, and industry partners – to critically evaluate new clinical data, evolving therapies, and emerging scientific concepts in an interactive, debate-centric format.

Staying true to its core mission, the 2026 gathering will build a bridge between science and clinical practice, showcasing pivotal new trials, next generation therapies (including CAR T cells and bispecific antibodies), the role of MRD, risk adapted strategies, and treatment approaches for elderly and high risk populations – all framed within lively expert discussions and audience engagement.

Designed as a boutique yet global event, COMy promotes in depth interactions. Participants benefit from structured debates and ample opportunity for Q&A, networking, and collaborative exchange – ensuring meaningful connections and insights in a focused scientific setting. This format has distinguished COMy as a unique, intimate forum where practice changing ideas are shaped through discourse.

We are confident that your participation in COMy 2026 will be both professionally rewarding and personally enriching. The insights gained, debates engaged, and connections made here will undoubtedly help advance patient care and the field of multiple myeloma worldwide.

We look forward to welcoming you to this landmark 12th edition of COMy.

Warm regards,